Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting the epigenome in malignant pleural mesothelioma

1 Jun 2017

Abstract excerpt

Malignant pleural mesotheliomas (MPM) are notoriously refractory to conventional treatment modalities. Recent insights regarding epigenetic alterations in MPM provide the preclinical rationale for the evaluation of novel combinatorial regimens targeting the epigenome in these neoplasms.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Occupational and environmental lung diseases
Share to Renal and related cancers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28713680
DOI: 10.21037/tlcr.2017.06.06

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting the epigenome in malignant pleural mesotheliomaPMID 28713680Read ↗

The role of epigenetics in malignant pleural mesotheliomaSemantic proximity Read ↗

CRISPR Screening Identifies WEE1 as a Combination Target for Standard Chemotherapy in Malignant Pleural MesotheliomaSemantic proximity Read ↗

Histone Deacetylase Inhibitors in Malignant Pleural Mesothelioma: Preclinical Rationale and Clinical TrialsSemantic proximity Read ↗

Immune Microenvironment and Genetics in Malignant Pleural MesotheliomaSemantic proximity Read ↗

Genomics and Functional Genomics of Malignant Pleural MesotheliomaSemantic proximity Read ↗

The cancer epigenome: Concepts, challenges, and therapeutic opportunities.Semantic proximity Read ↗

Integrative Molecular Characterization of Malignant Pleural Mesothelioma.Semantic proximity Read ↗

DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapySemantic proximity Read ↗

DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapySemantic proximity Read ↗

Molecular Fingerprints of Malignant Pleural Mesothelioma: Not Just a Matter of Genetic AlterationsSemantic proximity Read ↗

Epigenetic Profiles Distinguish Malignant Pleural Mesothelioma from Lung AdenocarcinomaSemantic proximity Read ↗

Multimodality treatment of malignant pleural mesotheliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.